Your Friday Briefing January 28, 2021 IFTTT +3 Mixed results from Novavax’s vaccine trials. NYT NYT > World > Europe NYTimes IFTTT Mixed results from Novavax’s vaccine trials. NYT NYT > World > Europe NYTimes